Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[First National Consensus on Chronic Hepatitis B].

Eduardo R Marín López1,

  • 1Servicio de Gastroenterología del Hospital de la Beneficencia Española de Puebla, Puebla, Pue. e_marin@prodigy.net.mx

Revista De Gastroenterologia De Mexico
|October 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Biliary tract diseases. Cholestasis].

Revista de gastroenterologia de Mexico·2010
Same author

[Speech for the Presidency office of the Mexican Association of Gastroenterology 2004].

Revista de gastroenterologia de Mexico·2004
Same author

Transcystic common bile duct exploration in the management of patients with choledocholithiasis.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2003
Same journal

[Severe bowel complications in SARS-CoV-2 patients receiving protocolized care].

Revista de gastroenterologia de Mexico·2024
Same journal

[Liver injury due to COVID-19 in critically ill adult patients. A retrospective study].

Revista de gastroenterologia de Mexico·2023
Same journal

[Reactive ileal lymphoid hyperplasia related to SARS-CoV-2 infection as a unique clinical feature resembling Crohn's disease].

Revista de gastroenterologia de Mexico·2022
Same journal

[Intestinal pseudo-obstruction: A rare presentation of congenital hypothyroidism].

Revista de gastroenterologia de Mexico·2022
Same journal

[Impact on the incidence of gastrointestinal perforation during the COVID-19 pandemic in the <i>Costa del Sol</i> healthcare system area].

Revista de gastroenterologia de Mexico·2022
Same journal

[Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one].

Revista de gastroenterologia de Mexico·2021
See all related articles

Mexican experts created the First National Consensus on Chronic Hepatitis B, integrating new diagnostics and antivirals for improved patient management and high-risk group approaches. This consensus aims to simplify complex aspects of Hepatitis B care.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Chronic Hepatitis B (CHB) remains a significant public health concern globally and in Mexico.
  • Advances in diagnostics, antivirals, and immunoprophylaxis necessitate updated clinical guidelines.
  • Previous lack of a unified national consensus hindered optimal CHB management in Mexico.

Framework:

  • The First National Consensus on Chronic Hepatitis B convened 34 leading Mexican experts in Hepatology, Gastroenterology, Infectology, Pediatrics, Oncology, Pathology, and Molecular Biology.
  • The consensus aimed to synthesize current knowledge and establish evidence-based recommendations for CHB.
  • Discussions focused on integrating new diagnostic methods, understanding disease natural history, and applying novel therapeutic agents.

Implementation:

Related Experiment Videos

  • The consensus addresses the practical application of sensitive diagnostic methods for HBV infection.
  • It provides guidance on the appropriate use of passive and active immunoprophilaxis strategies.
  • Recommendations cover the management of infected patients, including the use and indications for new antiviral therapies.

Implications:

  • This consensus provides a foundational framework for improving the clinical practice of CHB management in Mexico.
  • It aims to demystify complex aspects of Hepatitis B, including molecular biology and serologic markers.
  • The initiative is expected to enhance the approach to high-risk populations and optimize patient outcomes through standardized care.